Related Experiment Video
Updated: Jun 6, 2026

A Semi-Quantitative Drug Affinity Responsive Target Stability (DARTS) assay for studying Rapamycin/mTOR interaction
Published on: August 27, 2019
Decrease in transient receptor potential melastatin 6 mRNA stability caused by rapamycin in renal tubular epithelial
Akira Ikari1, Ayumi Sanada, Hayato Sawada
1Department of Pharmaco-Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka 422-8526, Japan. ikari@u-shizuoka-ken.ac.jp
Abstract:
Rapamycin, an inhibitor of mammalian target of rapamycin (mTOR), is used in treatments for transplantation and cancer. Rapamycin causes hypomagnesemia, although precisely how has not been examined. Here, we investigated the effect of rapamycin on the expression of transient receptor potential melastatin 6 (TRPM6), a Mg2+ channel. Rapamycin and LY-294002, an inhibitor of phosphatidilinositol-3 kinase (PI3K) located upstream of mTOR, inhibited epidermal growth factor (EGF)-induced expression of the TRPM6 protein without affecting TRPM7 expression in rat renal NRK-52E epithelial cells. Both rapamycin and LY-294002 decreased EGF-induced Mg2+ influx. U0126, a MEK inhibitor, inhibited EGF-induced increases in c-Fos, p-ERK, and TRPM6 levels. In contrast, neither rapamycin nor LY-294002 inhibited EGF-induced increases in p-ERK and c-Fos levels. EGF increased p-Akt level, an effect inhibited by LY-294002 and 1L-6-hydroxymethyl-chiro-inositol2-[(R)-2-O-methyl-3-O-octadecylcarbonate] (Akt inhibitor). Akt inhibitor decreased TRPM6 level similar to rapamycin and LY-294002. These results suggest that a PI3K/Akt/mTOR pathway is involved in the regulation of TRPM6 expression. Rapamycin inhibited the EGF-induced increase in TRPM6 mRNA but did not inhibit human TRPM6 promoter activity. In the presence of actinomycin D, a transcriptional inhibitor, rapamycin accelerated the decrease in TRPM6 mRNA. Rapamycin decreased the expression and activity of a luciferase linked with the 3'-untranslated region of human TRPM6 mRNA. These results suggest that TRPM6 expression is up-regulated by a PI3K/Akt/mTOR pathway and rapamycin reduces TRPM6 mRNA stability, resulting in a decrease in the reabsorption of Mg2+.
Insights
Rapamycin, an mTOR inhibitor, reduces magnesium (Mg2+) reabsorption by decreasing TRPM6 expression. This occurs via reduced mRNA stability, not altered transcription, suggesting a PI3K/Akt pathway regulates TRPM6.
Area of Science:
- Molecular Biology
- Cell Physiology
- Pharmacology
Background:
- Rapamycin (mTOR inhibitor) is used in transplantation and cancer treatments.
- Rapamycin is known to cause hypomagnesemia (low magnesium levels).
- The precise mechanism behind rapamycin-induced hypomagnesemia remains unclear.
Purpose of the Study:
- To investigate the effect of rapamycin on transient receptor potential melastatin 6 (TRPM6) expression.
- To elucidate the molecular pathway regulating TRPM6 and its connection to rapamycin's action.
- To understand how rapamycin influences magnesium (Mg2+) transport.
Main Methods:
- Utilized rat renal NRK-52E epithelial cells.
- Administered rapamycin, LY-294002 (PI3K inhibitor), U0126 (MEK inhibitor), and Akt inhibitor.
- Measured TRPM6 and TRPM7 protein expression, Mg2+ influx, and mRNA levels.
- Assessed effects on signaling pathways (ERK, Akt, c-Fos) and TRPM6 promoter activity.
- Analyzed mRNA stability using actinomycin D and 3'-untranslated region (UTR) reporter assays.
Main Results:
- Rapamycin and LY-294002 inhibited epidermal growth factor (EGF)-induced TRPM6 protein expression and Mg2+ influx.
- The PI3K/Akt pathway, but not ERK/MAPK, was implicated in EGF-induced TRPM6 expression.
- Rapamycin reduced TRPM6 mRNA levels by decreasing mRNA stability, not transcription, affecting the 3'-UTR.
Conclusions:
- A PI3K/Akt/mTOR pathway regulates TRPM6 expression.
- Rapamycin reduces Mg2+ reabsorption by destabilizing TRPM6 mRNA.
- This study clarifies a mechanism for rapamycin-induced hypomagnesemia.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability
RNA Stability
MicroRNAs
MicroRNAs

